This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Assistance Publique-Hopitaux De Paris, Biomedical Research Foundation of the Academy of Athens, Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2022.
Company Filing History:
1 out of 331 
1 out of 4 
1 out of 8,819 
Years Active: 2022
Title: Antonia Vlahou: Innovator in Cancer Biomarkers
Introduction
Antonia Vlahou is a distinguished inventor based in Athens, Greece. She has made significant contributions to the field of cancer diagnostics, particularly through her innovative work on bladder cancer biomarker proteins. Her research focuses on the development of methods and products that enhance the accuracy of cancer diagnosis and prognosis.
Latest Patents
Antonia Vlahou holds a patent for her invention related to bladder cancer biomarker proteins. This invention encompasses a collection of signature peptides representing at least 10 proteins that are utilized in cancer diagnosis and prognosis. It includes an artificial protein composed of these signature peptides and a nucleic acid construct encoding for such an artificial protein. Furthermore, her invention outlines a method for cancer diagnosis that involves analyzing at least 10 proteins in a urine sample from a subject. Additionally, it features an immunoassay product that comprises antibodies for detecting these proteins.
Career Highlights
Throughout her career, Antonia has worked with notable organizations, including Polyquant GmbH and the Commissariat à l'Énergie Atomique et aux Énergies Alternatives. Her experience in these companies has allowed her to advance her research and contribute to the scientific community.
Collaborations
Antonia has collaborated with esteemed colleagues such as Jerome Garin and Christophe Masselon. These partnerships have further enriched her research and innovation in the field of cancer diagnostics.
Conclusion
Antonia Vlahou is a pioneering inventor whose work on bladder cancer biomarker proteins has the potential to significantly impact cancer diagnosis and prognosis. Her contributions to the field exemplify the importance of innovation in medical research.